The
group has hired Morgan Stanley to conduct a strategic review of
its infant formula unit Mead Johnson in Greater China, the
sources said, declining to comment as the information is
confidential.
A sale process could start in the second quarter after the bank
gets initial feedback from potential buyers, which include both
strategic and private equity firms, the sources said.
They however cautioned no decision has been made and that
business valuation could change due to the impact of COVID-19.
Reckitt Benckiser did not immediately respond to a request for
comment while Morgan Stanley declined to comment.
The group announced the strategic review in February, saying
multiple options were being explored.
Its Greater China infant formula business represents 6% of group
sales, which were almost 14 billion pounds ($19.8 billion) in
2020, up 11.8% year-on-year, Reckitt Benckiser said at the time.
U.S.-headquartered Mead Johnson, which Reckitt Benckiser bought
for $16.6 billion in 2017, runs a range of infant formula brands
including Enfamil, Enfapro and Lactum.
Laxman Narasimhan, Reckitt Benckiser's chief executive, said in
February that challenges to the China business included Hong
Kong's longer-than-expected border closure during COVID-19,
local competition, a changing regulatory environment and lower
birth rates in the country.
Chinese consumers have been favouring imported infant formula
since the country's 2008 baby milk contamination scandal. The
top four best-selling infant formula brands on e-commerce
platform JD.COM for example are all foreign.
However, local brands are catching up fast with brands such as
Morgan Stanley-backed Feihe gaining significant market share.
China imported 335,600 tonnes of infant formula in 2020, down
2.8% year-on-year, according to the Dairy Association of China.
(Reporting by Kane Wu in Hong Kong, additional reporting by
Pamela Barbaglia in London; Editing by Emelia Sithole-Matarise)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|